GlaxoSmithKline | GSK - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 384.69B 19.14B 2026-03
Alcon AG USD 37.06B 5.98B 2026-03
Almirall EUR 2.39B 61.32M 2026-07
Amgen USD 189.89B 13.64B 2026-03
argenx SE USD 48.46B 9.17B 2026-07
AstraZeneca USD 197.73B 92.26B 2026-07
Bayer EUR 38.69B 2.33B 2026-03
Biogen USD 31.46B 4.55B 2026-07
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Fresenius Medical Care EUR 11.32B 642.58M 2026-03
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 82.78B 2.64B 2026-07
Glaxosmithkline GBP 108.55B 736M 2026-07
GRIFOLS EUR 4.5B 1.09B 2026-07
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Lakefront Biotherapeutics EUR 1.73B 119.93M 2026-03
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 46.78B 6.52B 2026-03
Merck USD 297.1B 35.84B 2026-03
Novartis USD 264.25B 23.66B 2026-07
Novo Nordisk A/S DKK 1.03T 421.31B 2026-03
Orion EUR 7.95B 2.2B 2026-07
Pfizer USD 153.81B 12.24B 2026-03
Philips EUR 20.31B 2.78B 2026-07
Recordati EUR 10.58B 327.34M 2026-07
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 235.82B 34.18B 2026-07
Sanofi EUR 100.27B 605.48M 2026-03
Smith & Nephew USD 3.47B 9.85B 2026-07
UCB EUR 46.41B 13.94B 2025-12